ISO/IEC 17025 accredited laboratory testing. Certificate of Analysis with every order. QR code on every vial.
Long-acting GHRH analog studied for GH release research.
CJC-1295 with DAC is a long-acting GHRH analog studied for sustained stimulation of growth hormone and downstream IGF-1 signaling. The DAC component binds to albumin and extends the compound’s half-life, making its profile different from shorter-acting GHRH analogs. In research, CJC-1295 with DAC is used to study prolonged GH-axis activation, endocrine rhythm changes, body-composition markers, recovery biology, and age-related hormone signaling. Scientists are especially interested in how long-acting GHRH analogs compare with shorter pulsatile agents in terms of duration, feedback response, and overall endocrine pathway behavior.
Your cart is empty.
Your Information